We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
Cap. Flow
+$47.8M
Cap. Flow %
7.17%
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644

Top Buys

Rank Stock Value
1
RLAY icon
Relay Therapeutics
RLAY
+$3.83M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$3M
3
TECK icon
Teck Resources
TECK
+$2.87M
4
MODV
ModivCare
MODV
+$2.67M
5
G icon
Genpact
G
+$2.6M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.07M
2
CHS
Chicos FAS, Inc.
CHS
+$2.68M
3
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$2.45M
4
CXT icon
Crane NXT
CXT
+$2.44M
5
ATCO
Atlas Corp.
ATCO
+$2.27M

Sector Composition

Rank Sector Weight
1 Healthcare 18.12%
2 Technology 15.11%
3 Consumer Discretionary 12.76%
4 Industrials 12.53%
5 Financials 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LRN icon
1626
Stride
LRN
$3.32B
– –
-10,787
Closed -$392K
LTC
1627
LTC Properties
LTC
$2.13B
– –
-10,782
Closed -$415K
LUV icon
1628
Southwest Airlines
LUV
$23B
– –
-5,757
Closed -$264K
LVO icon
1629
LiveOne
LVO
$56.9M
– –
-35,660
Closed -$291K
LX
1630
LexinFintech Holdings
LX
$239M
– –
-13,316
Closed -$35K
LXU icon
1631
LSB Industries
LXU
$698M
– –
-15,607
Closed -$341K
LYEL icon
1632
Lyell Immunopharma
LYEL
$348M
– –
-2,350
Closed -$237K
MAS icon
1633
Masco
MAS
$14.9B
– –
-6,239
Closed -$318K
MASI
1634
DELISTED
Masimo
MASI
– –
-1,486
Closed -$216K
MATW icon
1635
Matthews International
MATW
$863M
– –
-29,145
Closed -$943K
MBIN icon
1636
Merchants Bancorp
MBIN
$2.48B
– –
-8,000
Closed -$219K
MCHP icon
1637
Microchip Technology
MCHP
$40.4B
– –
-3,149
Closed -$237K
MD icon
1638
Pediatrix Medical
MD
$2.15B
– –
-24,610
Closed -$578K
MDU icon
1639
MDU Resources
MDU
$4.34B
– –
-120,685
Closed -$1.22M
MED icon
1640
Medifast
MED
$136M
– –
-1,586
Closed -$271K
ONT
1641
Onterris Inc
ONT
$530M
– –
-9,485
Closed -$502K
LITS
1642
Lite Strategy Inc
LITS
$31.6M
– –
-3,046
Closed -$37K
META icon
1643
Meta Platforms (Facebook)
META
$1.5T
– –
-4,975
Closed -$1.11M
MFA
1644
MFA Financial
MFA
$915M
– –
-15,439
Closed -$249K
MGM icon
1645
MGM Resorts International
MGM
$11.2B
– –
-6,519
Closed -$273K
MGNI icon
1646
Magnite
MGNI
$3.49B
– –
-14,346
Closed -$190K
MGRC icon
1647
McGrath RentCorp
MGRC
$2.97B
– –
-3,759
Closed -$319K
MIDD icon
1648
Middleby
MIDD
$6.03B
– –
-3,466
Closed -$568K
MIRM icon
1649
Mirum Pharmaceuticals
MIRM
$5.74B
– –
-14,869
Closed -$327K
MLCO icon
1650
Melco Resorts & Entertainment
MLCO
$2.14B
– –
-96,231
Closed -$735K
64 65
66
67 68

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.

  • GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
  • GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
  • GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
  • GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
  • GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
  • GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.